All News Bionomics Limited

Equities

BNOX

US09063M2052

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-16 pm EDT			5-day change	1st Jan Change
0.9228 ^USD	+0.30%		-4.20%	-37.64%

Mar. 21	Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	CI
Mar. 15	Bionomics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	Mar. 21	AQ
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	Mar. 21	CI
Bionomics : Notes to the Consolidated Financial Statements - Form 6-K	Mar. 15	PU
Bionomics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 15	CI
Bionomics to Present at the 2024 BIO CEO & Investor Conference	Feb. 22	AQ
Small-Cap Nasdaq Stocks to Watch Now! VTAK, BNOX, INBS, DYAI, KAVL	Jan. 29	AQ
Wall Street Set to Open Higher in Monday Trading Ahead of Economic Indicators Data	Jan. 22	MT
US Futures Poised to Open Week Higher, Leading Economic Indicators on Tap	Jan. 22	MT
Bionomics Provides a Review of 2023 and of 2024 Plans	Jan. 22	AQ
Bionomics to Present at Biotech Showcase™ 2024	Jan. 05	AQ
Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting	Dec. 06	AQ
Bionomics : Results of Annual General Meeting - Form 6-K	Nov. 30	PU
Bionomics : • Operations Presentation	Nov. 30	PU
Bionomics : Announces Retirement of Board Member - Form 6-K	Nov. 28	PU
Bionomics Limited Announces Retirement of Dr. Errol De Souza as Board of Directors, Effective November 30, 2023	Nov. 28	CI
Bionomics : Announces Retirement of Board Member	Nov. 27	PU
ADRs End Higher, Yoshitsu Co. Ltd. Climbs 19.2%	Nov. 10	DJ
Bionomics : Notice of Annual General Meeting Explanatory Statement and Proxy Form - Form 6-K	Nov. 03	PU
Bionomics to Advance Social Anxiety Disorder Treatment Into Phase 3 Studies After End-of-Phase 2 Meeting With US FDA	23-10-16	MT
Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder	23-10-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Bionomics Limited

Equities

BNOX

US09063M2052

All News

Filters